BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32634120)

  • 41. Atypical Polycystic Kidney Disease as defined by Imaging.
    Iliuta IA; Win AZ; Lanktree MB; Lee SH; Pourafkari M; Nasri F; Guiard E; Haghighi A; He N; Ingram A; Quist C; Hillier D; Khalili K; Pei Y
    Sci Rep; 2023 Feb; 13(1):2952. PubMed ID: 36807559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease.
    Magistroni R; He N; Wang K; Andrew R; Johnson A; Gabow P; Dicks E; Parfrey P; Torra R; San-Millan JL; Coto E; Van Dijk M; Breuning M; Peters D; Bogdanova N; Ligabue G; Albertazzi A; Hateboer N; Demetriou K; Pierides A; Deltas C; St George-Hyslop P; Ravine D; Pei Y
    J Am Soc Nephrol; 2003 May; 14(5):1164-74. PubMed ID: 12707387
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum Uric Acid and Progression of Autosomal Dominant Polycystic Kidney Disease: Results from the HALT PKD Trials.
    Brosnahan GM; You Z; Wang W; Gitomer BY; Chonchol M
    Curr Hypertens Rev; 2021; 17(3):228-237. PubMed ID: 32807060
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characteristics of Patients with End-Stage Kidney Disease in ADPKD.
    Shukoor SS; Vaughan LE; Edwards ME; Lavu S; Kline TL; Senum SR; Mkhaimer Y; Zaatari G; Irazabal MV; Neal R; Hogan MC; Zoghby ZM; Harris PC; Torres VE; Chebib FT
    Kidney Int Rep; 2021 Mar; 6(3):755-767. PubMed ID: 33732990
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aberrant PKD2 splicing due to a presumed novel missense mutation in autosomal-dominant polycystic kidney disease.
    Tan YC; Blumenfeld J; Michaeel A; Donahue S; Balina M; Parker T; Levine D; Rennert H
    Clin Genet; 2011 Sep; 80(3):287-92. PubMed ID: 20950398
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neonatal onset autosomal dominant polycystic kidney disease (ADPKD) in a patient homozygous for a PKD2 missense mutation due to uniparental disomy.
    Losekoot M; Ruivenkamp CA; Tholens AP; Grimbergen JE; Vijfhuizen L; Vermeer S; Dijkman HB; Cornelissen EA; Bongers EM; Peters DJ
    J Med Genet; 2012 Jan; 49(1):37-40. PubMed ID: 22114106
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of rapid disease progression in autosomal dominant polycystic kidney disease.
    Corradi V; Gastaldon F; Caprara C; Giuliani A; Martino F; Ferrari F; Ronco C
    Minerva Med; 2017 Feb; 108(1):43-56. PubMed ID: 27701376
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polycystic Kidney Disease without an Apparent Family History.
    Iliuta IA; Kalatharan V; Wang K; Cornec-Le Gall E; Conklin J; Pourafkari M; Ting R; Chen C; Borgo AC; He N; Song X; Heyer CM; Senum SR; Hwang YH; Paterson AD; Harris PC; Khalili K; Pei Y
    J Am Soc Nephrol; 2017 Sep; 28(9):2768-2776. PubMed ID: 28522688
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term effect of coffee consumption on autosomal dominant polycystic kidneys disease progression: results from the Suisse ADPKD, a Prospective Longitudinal Cohort Study.
    Girardat-Rotar L; Puhan MA; Braun J; Serra AL
    J Nephrol; 2018 Feb; 31(1):87-94. PubMed ID: 28386880
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-Term Outcomes in Patients with Very-Early Onset Autosomal Dominant Polycystic Kidney Disease.
    Nowak KL; Cadnapaphornchai MA; Chonchol MB; Schrier RW; Gitomer B
    Am J Nephrol; 2016; 44(3):171-8. PubMed ID: 27548646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnosis of autosomal-dominant polycystic kidney disease: an integrated approach.
    Barua M; Pei Y
    Semin Nephrol; 2010 Jul; 30(4):356-65. PubMed ID: 20807608
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Volume Progression and Imaging Classification of Polycystic Liver in Early Autosomal Dominant Polycystic Kidney Disease.
    Bae KT; Tao C; Feldman R; Yu ASL; Torres VE; Perrone RD; Chapman AB; Brosnahan G; Steinman TI; Braun WE; Mrug M; Bennett WM; Harris PC; Srivastava A; Landsittel DP; Abebe KZ;
    Clin J Am Soc Nephrol; 2022 Mar; 17(3):374-384. PubMed ID: 35217526
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Automated prognosis of renal function decline in ADPKD patients using deep learning.
    Raj A; Tollens F; Caroli A; Nörenberg D; Zöllner FG
    Z Med Phys; 2024 May; 34(2):330-342. PubMed ID: 37612178
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years.
    Dicks E; Ravani P; Langman D; Davidson WS; Pei Y; Parfrey PS
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):710-7. PubMed ID: 17699277
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials.
    Brosnahan GM; Abebe KZ; Rahbari-Oskoui FF; Patterson CG; Bae KT; Schrier RW; Braun WE; Chapman AB; Flessner MF; Harris PC; Perrone RD; Steinman TI; Torres VE;
    Curr Hypertens Rev; 2017; 13(2):109-120. PubMed ID: 28460625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessing the Risk of Progression to Kidney Failure in Patients With Autosomal Dominant Polycystic Kidney Disease.
    Lanktree MB; Kline T; Pei Y
    Adv Kidney Dis Health; 2023 Sep; 30(5):407-416. PubMed ID: 38097331
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.
    Park HC; Kim J; Cho A; Kim DH; Lee YK; Ryu H; Kim H; Oh KH; Oh YK; Hwang YH; Lee KB; Kim SW; Kim YH; Lee J; Ahn C;
    J Korean Med Sci; 2020 Jun; 35(22):e165. PubMed ID: 32508065
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Baseline characteristics of the autosomal-dominant polycystic kidney disease sub-cohort of the KoreaN cohort study for outcomes in patients with chronic kidney disease.
    Kim H; Koh J; Park SK; Oh KH; Kim YH; Kim Y; Ahn C; Oh YK
    Nephrology (Carlton); 2019 Apr; 24(4):422-429. PubMed ID: 29797773
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kidney enlargement and multiple liver cyst formation implicate mutations in PKD1/2 in adult sporadic polycystic kidney disease.
    Fujimaru T; Mori T; Sekine A; Mandai S; Chiga M; Kikuchi H; Ando F; Mori Y; Nomura N; Iimori S; Naito S; Okado T; Rai T; Hoshino J; Ubara Y; Uchida S; Sohara E
    Clin Genet; 2018 Jul; 94(1):125-131. PubMed ID: 29520754
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic approach in autosomal dominant polycystic kidney disease.
    Pei Y
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1108-14. PubMed ID: 17699332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.